77 related articles for article (PubMed ID: 8680808)
1. Effect of glutathione depletion by buthionine sulfoximine on doxorubicin toxicity in mice.
Kisara S; Furusawa S; Takayanagi Y; Sasaki K
Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):401-10. PubMed ID: 8680808
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
3. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
Wu HY; Kang YJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
Wong M; Helston LM; Wells PG
Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848
[TBL] [Abstract][Full Text] [Related]
6. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells.
Paranka NS; Dorr RT
Anticancer Res; 1994; 14(5A):2047-52. PubMed ID: 7847848
[TBL] [Abstract][Full Text] [Related]
7. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
8. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
Ford JM; Yang JM; Hait WN
Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108
[TBL] [Abstract][Full Text] [Related]
9. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
Reliene R; Schiestl RH
Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
[TBL] [Abstract][Full Text] [Related]
10. Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in mice.
Soble MJ; Dorr RT
Anticancer Res; 1988; 8(1):17-22. PubMed ID: 3358633
[TBL] [Abstract][Full Text] [Related]
11. The effect of L-buthionine-[S,R]-sulfoximine on the pancreas in mice. A model of weakening glutathione-based defense mechanisms.
Lüthen RE; Neuschwander-Tetri BA; Niederau C; Ferrell LD; Grendell JH
Int J Pancreatol; 1994 Aug; 16(1):31-6. PubMed ID: 7528760
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of 3H-1,2-dithiole-3-thione-induced glutathione, glutathione S-transferase and aldose reductase in protecting against 4-hydroxy-2-nonenal toxicity in cultured cardiomyocytes.
Li Y; Cao Z; Zhu H; Trush MA
Arch Biochem Biophys; 2005 Jul; 439(1):80-90. PubMed ID: 15946642
[TBL] [Abstract][Full Text] [Related]
13. Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion.
Mérad-Saïdoune M; Boitier E; Nicole A; Marsac C; Martinou JC; Sola B; Sinet PM; Ceballos-Picot I
Exp Neurol; 1999 Aug; 158(2):428-36. PubMed ID: 10415149
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice.
Li XM; Metzger G; Filipski E; Boughattas N; Lemaigre G; Hecquet B; Filipski J; Levi F
Toxicol Appl Pharmacol; 1997 Apr; 143(2):281-90. PubMed ID: 9144445
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of heat shock protein mRNAs under in vivo glutathione depletion in the mouse retina.
Park JW; Moon C; Yun S; Kim SY; Bae YC; Chun MH; Moon JI
Neurosci Lett; 2007 Feb; 413(3):260-4. PubMed ID: 17197086
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
17. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence for glutathione as mediator of apoptosis in neuronal cells.
Nicole A; Santiard-Baron D; Ceballos-Picot I
Biomed Pharmacother; 1998; 52(9):349-55. PubMed ID: 9856280
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity.
Jia Z; Misra BR; Zhu H; Li Y; Misra HP
Neurotoxicology; 2009 Jan; 30(1):1-9. PubMed ID: 19073213
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
